RIGLRigel Pharmaceuticals, Inc.
45.89USD-2.28%Mkt Cap: 849.06M $P/E: 2.683d ago
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral s…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap849.06M $
Enterprise Value789.88M $
Revenue (TTM)276.78M $
Gross Profit274.66M $
Net Income (TTM)367.02M $
Revenue/Share15.12 USD
Last Price45.89 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees172
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS7665596034
Valuation
P/E (Trailing)2.68
P/E (Forward)9.16
PEG—
EV/EBITDA8.81
EV/Revenue2.85
P/S3.05
P/B1.98
EPS (TTM)16.29
EPS (Forward)4.94
52W Range
24.9577% of range52.24
52W High52.24 USD
52W Low24.95 USD
Profitability
Gross Margin93.33%
Oper. Margin29.95%
EBITDA Margin32.41%
Profit Margin124.72%
ROE93.75%
ROA71.46%
Growth
Revenue Growth-22.60%
Earnings Growth-73.20%
Cash Flow & Leverage
Operating CF75.66M $
CapEx (TTM)—
FCF Margin-11.47%
FCF Yield-3.74%
Net Debt-55.38M $
Net Debt/EBITDA-0.62
Balance Sheet
Debt/Equity0.14
Current Ratio1.94
Quick Ratio1.58
Book Value/Sh22.81 USD
Cash/Share5.103 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 27, 2024
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)63.00 USD
Upside (mean)+37.3%
Target Range43.00 USD – 85.00 USD
$43.00+37.3% to mean$85.00
# Analysts5
Ownership
Shares Out.18.50M
Float14.85M
Insiders3.36%
Institutions89.27%
Short Interest
Short Ratio8.9d
Short % Float17.00%
Short % Out.16.56%
Shares Short3.09M
Short (prev mo.)3.25M
Technical
SMA 5038.96 (+17.8%)
SMA 20035.82 (+28.1%)
Beta1.17
S&P 52W Chg18.16%
Avg Vol (30d)293.88K
Avg Vol (10d)328.17K
Technical Indicators
RSI (14)67.8
MACD1.7711
MACD Signal1.1889
MACD Hist.+0.5822
BB Upper45.98 USD
BB Middle40.18 USD
BB Lower34.38 USD
BB Width28.88%
ATR (14)2.103 USD
Vol Ratio (20d)1.14x